ArticleGastroenterology research and practice2026
Analysis of the Risk Factors for Short-Term Outcomes in Acute Small Bowel Obstruction: A Retrospective Study.
Article in Gastroenterology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of the Risk Factors for Short-Term Outcomes in Acute Small Bowel Obstruction: A Retrospective Study.Gastroenterology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the lack of analysis on risk factors for the short-term outcomes of acute small bowel obstruction (ASBO), the current high readmission rate and severe postoperative complications of ASBO seriously affect the quality of life of patients. Risk-scoring models for evaluating the short-term outcomes of ASBO are still urgently needed. Methods: A total of 278 patients diagnosed with complete ASBO were included in this study. Cox proportional hazards regression analysis was used to construct predictive models for the length of stay (LOS) and the length of short-term recurrence (LOR). The receiver operating characteristic (ROC) curves and the area under the curve (AUC) were calculated to assess the performance. Results: The mean LOS of 278 patients was 11.19 days, and 17 patients (6.1%) were readmitted. Multivariate analysis showed that longer duration of disease (Hazard ratio, HR = 1.551), low albumin (HR = 1.681), high lumen diameter(max) (HR = 1.477), low chlorine (HR = 1.046), and operation (HR = 7.456) were risk factors for LOS. Calcium (HR = 29.391) was an independent risk factor for LOR. Operation is not a risk factor for LOR. A risk-scoring model of LOS (RS_LOS) was constructed to predict the posttreatment recovery (AUC, 30 days = 0.859). In the high-risk group, the severe adverse events (SAE) rate reached 17.1%, exceeding 1.4% in the low-risk group. The performance of RS_LOR was also satisfactory (AUC, 12 months = 0.802). In the high-risk group, the recurrence rate reached 14.3%, nearly triple that in the low-risk group (3.4%). Conclusion: The risk-scoring models of LOS and LOR provide a comprehensive evaluation on the short-term outcomes of ASBO treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.